CMTM7 and breast cancer: On the basis of above literature and findings, we proposed the hypothesis that breast cancer cell derived-encapsulated miR-182-5p regulates the CMTM7/EGFR/AKT signaling pathway, thus contributing to the development and progression of breast cancer.